Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b

Status:
Recruiting

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

This study is to investigate the clinical efficacy and safety of three types of nucleotide/nucleoside analogues in treatment of chronic hepatitis b

N/A

Third Affiliated Hospital, Sun Yat-Sen University

Entecavir
Tenofovir